Boehringer Ingelheim Investigational Site

Orlando, Florida 32804

0 studies enrolling now · 4 studies all time

What they study most

Arthritis, Rheumatoid, Atrial Fibrillation, HIV Infections

Studies at this site

• Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients — Completed
• 3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study — Completed
• Management of Gastrointestinal and Urogenital (GI/GU) Bleedings in Atrial Fibrillation Patients Using Pradaxa — Completed
• A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis — Completed